TONON, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 567
NA - Nord America 552
AS - Asia 32
AF - Africa 6
OC - Oceania 5
Totale 1.162
Nazione #
US - Stati Uniti d'America 551
SE - Svezia 391
IT - Italia 114
FI - Finlandia 15
CN - Cina 14
IE - Irlanda 14
DE - Germania 11
IN - India 8
NL - Olanda 7
CM - Camerun 5
GB - Regno Unito 5
AU - Australia 4
FR - Francia 3
ID - Indonesia 2
IR - Iran 2
MK - Macedonia 2
RU - Federazione Russa 2
TR - Turchia 2
TW - Taiwan 2
BW - Botswana 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
SI - Slovenia 1
Totale 1.162
Città #
Ashburn 140
Lawrence 139
Princeton 139
Milan 67
New York 25
Dublin 14
Helsinki 14
Shanghai 14
Seattle 8
Segrate 8
Pune 7
Los Angeles 6
Washington 6
Amsterdam 5
Bologna 4
Elsternwick 4
Sheffield 4
Bergamo 3
Framingham 3
Ingolstadt 3
Rome 3
Somma Lombardo 3
Brembate di Sopra 2
Carrara 2
Cittadella 2
Dijon 2
Parma 2
Skopje 2
Vaprio d'Adda 2
Zola Predosa 2
Acerra 1
Andover 1
Ankara 1
Baltimore 1
Bekasi 1
Cambridge 1
Castello di Cisterna 1
Cluj-Napoca 1
Coimbatore 1
Dearborn 1
Gaborone 1
Genoa 1
Gustavo Adolfo Madero 1
Hanover 1
Houston 1
Izmir 1
Lappeenranta 1
Legnano 1
Ljubljana 1
Manila 1
Mountain View 1
Naaldwijk 1
Orlando 1
Oxford 1
Palermo 1
Pinehaven 1
Redwood City 1
Tehran 1
Udine 1
Totale 664
Nome #
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 33
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 29
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation 29
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 21
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 19
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches. 19
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 18
Chest CT in the emergency department for suspected COVID-19 pneumonia 17
A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability 17
C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications 16
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 15
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 15
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus 14
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy 14
K-ras activation generates an inflammatory response in lung tumors 14
Iron increases the susceptibility of multiple myeloma cells to bortezomib 13
A next generation sequencing study in Italian multiplex families with multiple sclerosis 13
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism 12
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation (Scientific Reports, (2020), 10, 1, (16906), 10.1038/s41598-020-73835-1) 12
CS1, a new surface target on multiple myeloma (MM) cells, protects myeloma cells from apoptosis via-regulation of ERKI/2, AKT and STAT3 signaling cascades 12
H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing 12
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection 11
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression 11
MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer 11
Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features 11
Karotypic complexity of the "NCI-60" drug-screening panel 11
Genetic distance, transportation costs, and trade 11
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer 10
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 10
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma 10
Karyotypic "state" as a potential determinant for anticancer drug discovery. 10
STK4 inhibitors for treatment of hematological malignancies 10
An Oncogene-Regulated Epigenetic Switch in T Cell Acute Lymphoblastic Leukemia 10
A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands 10
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway 10
Somatic mutations affect key pathways in lung adenocarcinoma 10
C-jun and C-ABL in human multiple myeloma cell death 10
Plasma homocysteine levels in 10 patients with polycythemia. 10
Karyotypic complexity of the NCI-60 drug-screening panel. 10
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. 10
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 9
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 9
Analyzing genomic and epigenetic profiles in single cells by hybrid transposase (scGET-seq) 9
Lymphoma/myeloma 9
JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment 9
Bone Marrow Endosteal Mesenchymal Progenitors Depend on HIF Factors for Maintenance and Regulation of Hematopoiesis 9
Targeting PKC informs in MM by enzastaurin (LY317615.HCL) 9
Loss of the histone demethylase UTX alters the gene expression prolife and contributes to the malignant phenotype of multiple myeloma cells 9
Compositions, Kits, and Methods for identification, assessment, prevention, and therapy of cancer 9
Novel Targets in Multiple Myeloma and Other Disorders 9
Detection of MECT1-MAML2 fusion products 9
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets 9
HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF DIS3 MUTATIONS IN MULTIPLE MYELOMA 9
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans 9
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 9
Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128-350 triggers MM cell death via c-Jun upregulation 9
The MEK1/2 inhibitor AZD6244 (ARRY-142886) downregulates constitutive and adhesion-induced c-MAF oncogene expression and its downstream targets in human multiple myeloma 9
TARGETING ANGIOGENESIS VIA A C-MYC/HIF-1 alpha-DEPENDENT PATHWAY IN MM 9
Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. 9
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL 9
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS 9
Compositions, Kits, and Methods for identification, assessment, prevention, and therapy of cancer 9
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 8
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation 8
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 8
Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas 8
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition 8
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 8
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers 8
Up-regulation of c-Jun contributes to induction of apoptosis by Adaphostin in human multiple myeloma cells 8
Targeting proteinkinase C alters ER-stress and b-catenin signaling in multiple myeloma: Therapeutic implications 8
The AP-1 transcription factor JunB promotes multiple myeloma cell proliferation, survival and drug resistance in the bone marrow microenvironment 8
Spectral karyotyping (SKY) in combination with locus-specific FISH, a technique to simultaneously define genes and chromosomes involved in chromosomal translocations 8
Lentiviral Vector-Based Insertional Mutagenesis Identifies New Oncogenes and Molecular Networks That Control Hepatocyte Transformation and Metabolism 8
Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability 8
Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. 8
Molecular Pathogenesis of Multiple Myeloma 8
EXPLOITING IRON TOXICITY IN MULTIPLE MYELOMA: A STRATEGY TO INCREASE THE EFFICACY OF PROTEASOME INHIBITION THERAPIES 8
The small-molecule VEGF-receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma 8
The Tyrophostin Adaphostin (Nsc680410) Inhibits Multiple Myeloma Bone Marrow Angiogenesis In In Vitro And In Vivo 8
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 8
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer 7
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 7
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 7
Highly similar genomic landscapes in monoclonal b-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations 7
MUTATIONAL SPECTRUM OF BRAF, NRAS AND KRAS IN MULTIPLE MYELOMA 7
Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations. 7
The AP-1 Transcription Factor JunB Promotes Multiple Myeloma (MM) Cell Proliferation, Survival and Drug Resistance in the Bone Marrow Microenvironment 7
Targeting PKC: A Novel Role for Beta-catenin in ER Stress and Apoptotic Signaling 7
Upregulation of c-Jun induces cell death via caspase- triggered c-Abl cleavage in human multiple myeloma 7
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients 7
From oncogene to network addiction: the new frontier of cancer genomics and therapeutics. 7
KMD6A/UTX loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition 7
Loss of the Histone Demethylase UTX Contributes to Multiple Myeloma and Sensitizes Cells to EZH2 Inhibitors 7
Common and Contrasting Genomic Profiles Among The Major Human Lung Cancer Subtypes. 7
CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation 7
Telomere dysfunction induces metabolic and mitochondrial compromise. 7
Correlating array CGH with gene expression and sensitivity to drugs in a panel of 60 human cancer cell lines 7
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia 7
Identification of new human liver cancer genes by a novel lentiviral vector-based insertional mutagenesis approach in three mouse models of hepatocarcinogenesis 7
Totale 1.043
Categoria #
all - tutte 24.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 6 0 0 0 0 0 0 0 0 0 0 0
2020/202111 0 0 0 1 1 4 5 0 0 0 0 0
2021/2022158 0 0 0 12 2 0 2 123 2 11 1 5
2022/2023809 291 181 31 7 48 114 34 60 15 8 13 7
2023/2024354 10 14 48 126 32 53 15 30 1 25 0 0
Totale 1.348